Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Australian Influenza Vaccine Committee

AIVC recommendations for the composition of influenza vaccine for 2008

The Australian Influenza Vaccine Committee (AIVC) met on 3rd October 2007, and agreed to adopt the September WHO recommendations.

The Committee decided that the influenza vaccine components for the year 2008 Season should contain the following:

  • A (H1N1): an A/Solomon Islands/3/2006 (H1N1) - like strain, 15 µg HA per dose
  • A (H3N2): an A/Brisbane/10/2007 (H3N2) - like strain, 15 µg HA per dose
  • B: a B/Florida/4/2006 - like strain, 15 µg HA per dose

The following viruses are recommended as suitable vaccine strains:

  • A/Solomon Islands/3/2006 (H1N1) (IVR-145)
  • A/Brisbane/10/2007 (H3N2) (IVR-147)
  • B/Florida /4/2006 or B/Brisbane/3/2007

The SRID reference standard reagents for A/Solomon Islands/3/2006 (H1N1) (IVR-145) strain are available from NIBSC (UK).

The SRID reference standard reagents for A/Brisbane/10/2007 (H3N2) (IVR-147) and B/Brisbane/3/2007 strains will be available from TGA (Australia) following calibration in December 2007.